Aidian is your best partner when ensuring the best outcome for the expecting mother and the baby at the labor ward. Careful monitoring of the C-reactive protein (CRP) is simple with Aidian's QuikRead go® easy CRP, which provides quantitative CRP results within 2 minutes to support fast decision making. CRP is a widely used analyte to help assess the risk of infection and response to the antibiotic treatment in neonatal care settings1.
Nova Biomedical's high quality StatStrip® Glucose monitoring system is available in the Nordics through Aidian and suitable for all patient groups, including neonates. StatStrip Glucose is the only glucose meter that measures and eliminates glucose interferences from hematocrit, galactose, and other endogenous and exogenous substances2. StatStrip Lactate testing of scalp blood lactate levels can be used for fetal surveillance during labor with extensively studied lactate thresholds for fetal acidemia3. Nova StatStrip meters are available as connected and non-connected meter versions for lactate; lactate, hemoglobin, hematocrit; and glucose, ketone. Nova StatStrip Glucose monitoring system is the only glucose meter technology cleared by the U.S. FDA for use with all patients, including critically ill4.
Aidian also offers Meridian's Revogene® GBS DS assay on the Revogene® platform for the detection of Group B Streptococcus (GBS) directly from vaginal/rectal samples at the time of delivery. The presence of GBS can be detected within 70 minutes and as early as 40 minutes for positive specimens.
Last but not least Biosynex's high quality rapid tests are available through Aidian for detecting PROM and assessing the risk of preterm delivery in gestation weeks 22 to 37. PROM is the premature rupture of fetal membranes before the onset of labor. Babies born too early can have an increased risk of breathing difficulties and longer stays in the neonatal intensive care unit5. However, staying in the womb for too long might cause serious infections for the mother and the baby. AMNIOQUICK® and PREMAQUICK® tests detect markers used to diagnose PROM and imminent delivery.
Read more from our flyer: Your partner in labor diagnostics*
- Hofer N, Zacharias E, Muller W et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012; 102(1): 25-36.
- DuBois JA, et al. Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings. Crit Care Med. 2017 Apr;45(4):567-574. doi: 10.1097/CCM.0000000000002252.
- Linda Iorizzo, Ylva Carlsson, Christel Johansson, et al. Proposed cut-off for fetal scalp blood lactate in intrapartum fetal surveillance based on neonatal outcomes: a prospective observational study. Authorea. March 12, 2021
- Bond DM, Middleton P, et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004735. doi: 10.1002/14651858.CD004735.pub4.